Patents by Inventor Hal Propp

Hal Propp has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20100268293
    Abstract: An implantable cardiac device detects a patient therapy request originating from external to the implantable device. A shock therapy delay period is timed in response to the detection of the patient therapy request. Atrial shock therapy is provided to the patient after expiration of the shock therapy delay period (if the presence of an ongoing atrial arrhythmia is detected). The patient therapy request may be provided by a patient activator including a magnet for operating a reed switch in the implanted device to provide the request. A patient activator including an input and receiver/transmitter circuitry may be employed to request the immediate providing of atrial shock therapy, and/or to set the duration the shock therapy delay period. By allowing specific delays to therapy after a therapy request, a patient can prepare for the requested therapy and thereby mitigate therapy discomfort.
    Type: Application
    Filed: June 30, 2010
    Publication date: October 21, 2010
    Inventors: Victor T. Chen, Gary T. Seim, Carlos Ricci, Michael L. Favet, Hal Propp
  • Publication number: 20100204742
    Abstract: An implanted cardiac device detects an atrial arrhythmia and provides periodically updated atrial arrhythmia status as long as the arrhythmia is ongoing. A patient may request an indication of ongoing atrial arrhythmia status from external to the patient using a patient activator. The patient activator may include a magnet for closing a reed switch in the implanted device to provide the request or may provide the request over a telemetry link to the implanted device. The implanted device may provide the requested atrial arrhythmia status and other information in the form of an audible tone produced by the implanted device or as a message telemetered from the implanted device to the patient activator. The patient activator may include a tone detector and display for providing a visual indication of the atrial arrhythmia status indication. The magnet activator may also be employed to request or withhold atrial shock therapy.
    Type: Application
    Filed: April 21, 2010
    Publication date: August 12, 2010
    Inventors: Victor T. Chen, Gary T. Seim, Hal Propp, LeAnne Eberle, Lynn TeWinkel
  • Patent number: 7761152
    Abstract: An implantable cardiac device detects a patient therapy request originating from external to the implantable device. A shock therapy delay period is timed in response to the detection of the patient therapy request. Atrial shock therapy is provided to the patient after expiration of the shock therapy delay period (if the presence of an ongoing atrial arrhythmia is detected). The patient therapy request may be provided by a patient activator including a magnet for operating a reed switch in the implanted device to provide the request. A patient activator including an input and receiver/transmitter circuitry may be employed to request the immediate providing of atrial shock therapy, and/or to set the duration the shock therapy delay period. By allowing specific delays to therapy after a therapy request, a patient can prepare for the requested therapy and thereby mitigate therapy discomfort.
    Type: Grant
    Filed: November 15, 2005
    Date of Patent: July 20, 2010
    Assignee: Cardiac Pacemakers, Inc.
    Inventors: Victor T. Chen, Gary T. Seim, Carlos Ricci, Michael L. Favet, Hal Propp
  • Patent number: 7706877
    Abstract: An implanted cardiac device detects an atrial arrhythmia and provides periodically updated atrial arrhythmia status as long as the arrhythmia is ongoing. A patient may request an indication of ongoing atrial arrhythmia status from external to the patient using a patient activator. The patient activator may include a magnet for closing a reed switch in the implanted device to provide the request or may provide the request over a telemetry link to the implanted device. The implanted device may provide the requested atrial arrhythmia status and other information in the form of an audible tone produced by the implanted device or as a message telemetered from the implanted device to the patient activator. The patient activator may include a tone detector and display for providing a visual indication of the atrial arrhythmia status indication. The magnet activator may also be employed to request or withhold atrial shock therapy.
    Type: Grant
    Filed: November 1, 2005
    Date of Patent: April 27, 2010
    Assignee: Cardiac Pacemakers, Inc.
    Inventors: Victor T. Chen, Gary T. Seim, Hal Propp, LeAnne Eberle, Lynn TeWinkel
  • Publication number: 20060079939
    Abstract: An implantable cardiac device detects a patient therapy request originating from external to the implantable device. A shock therapy delay period is timed in response to the detection of the patient therapy request. Atrial shock therapy is provided to the patient after expiration of the shock therapy delay period (if the presence of an ongoing atrial arrhythmia is detected). The patient therapy request may be provided by a patient activator including a magnet for operating a reed switch in the implanted device to provide the request. A patient activator including an input and receiver/transmitter circuitry may be employed to request the immediate providing of atrial shock therapy, and/or to set the duration the shock therapy delay period. By allowing specific delays to therapy after a therapy request, a patient can prepare for the requested therapy and thereby mitigate therapy discomfort.
    Type: Application
    Filed: November 15, 2005
    Publication date: April 13, 2006
    Inventors: Victor Chen, Gary Seim, Carlos Ricci, Michael Favet, Hal Propp
  • Patent number: 7024240
    Abstract: An implantable cardiac device detects a patient therapy request originating from external to the implantable device. A shock therapy delay period is timed in response to the detection of the patient therapy request. Atrial shock therapy is provided to the patient after expiration of the shock therapy delay period (if the presence of an ongoing atrial arrhythmia is detected). The patient therapy request may be provided by a patient activator including a magnet for operating a reed switch in the implanted device to provide the request. A patient activator including an input and receiver/transmitter circuitry may be employed to request the immediate providing of atrial shock therapy, and/or to set the duration the shock therapy delay period. By allowing specific delays to therapy after a therapy request, a patient can prepare for the requested therapy and thereby mitigate therapy discomfort.
    Type: Grant
    Filed: August 19, 2003
    Date of Patent: April 4, 2006
    Assignee: Cardiac Pacemakers, Inc.
    Inventors: Victor T. Chen, Gary T. Seim, Carlos Ricci, Michael L. Favet, Hal Propp
  • Publication number: 20060064132
    Abstract: An implanted cardiac device detects an atrial arrhythmia and provides periodically updated atrial arrhythmia status as long as the arrhythmia is ongoing. A patient may request an indication of ongoing atrial arrhythmia status from external to the patient using a patient activator. The patient activator may include a magnet for closing a reed switch in the implanted device to provide the request or may provide the request over a telemetry link to the implanted device. The implanted device may provide the requested atrial arrhythmia status and other information in the form of an audible tone produced by the implanted device or as a message telemetered from the implanted device to the patient activator. The patient activator may include a tone detector and display for providing a visual indication of the atrial arrhythmia status indication. The magnet activator may also be employed to request or withhold atrial shock therapy.
    Type: Application
    Filed: November 1, 2005
    Publication date: March 23, 2006
    Inventors: Victor Chen, Gary Seim, Hal Propp, LeAnne Eberle, Lynn TeWinkel
  • Patent number: 6980857
    Abstract: An implanted cardiac device detects an atrial arrhythmia and provides periodically updated atrial arrhythmia status as long as the arrhythmia is ongoing. A patient may request an indication of ongoing atrial arrhythmia status from external to the patient using a patient activator. The patient activator may include a magnet for closing a reed switch in the implanted device to provide the request or may provide the request over a telemetry link to the implanted device. The implanted device may provide the requested atrial arrhythmia status and other information in the form of an audible tone produced by the implanted device or as a message telemetered from the implanted device to the patient activator. The patient activator may include a tone detector and display for providing a visual indication of the atrial arrhythmia status indication. The magnet activator may also be employed to request or withhold atrial shock therapy.
    Type: Grant
    Filed: April 20, 2001
    Date of Patent: December 27, 2005
    Assignee: Cardiac Pacemakers, Inc.
    Inventors: Victor T. Chen, Gary T. Seim, Hal Propp, LeAnne Eberle, Lynn TeWinkel
  • Publication number: 20040034389
    Abstract: An implantable cardiac device detects a patient therapy request originating from external to the implantable device. A shock therapy delay period is timed in response to the detection of the patient therapy request. Atrial shock therapy is provided to the patient after expiration of the shock therapy delay period (if the presence of an ongoing atrial arrhythmia is detected). The patient therapy request may be provided by a patient activator including a magnet for operating a reed switch in the implanted device to provide the request. A patient activator including an input and receiver/transmitter circuitry may be employed to request the immediate providing of atrial shock therapy, and/or to set the duration the shock therapy delay period. By allowing specific delays to therapy after a therapy request, a patient can prepare for the requested therapy and thereby mitigate therapy discomfort.
    Type: Application
    Filed: August 19, 2003
    Publication date: February 19, 2004
    Applicant: Cardiac Pacemakers, Inc.
    Inventors: Victor T. Chen, Gary T. Seim, Carlos Ricci, Michael L. Favet, Hal Propp
  • Patent number: 6618617
    Abstract: An implantable cardiac device detects a patient therapy request originating from external to the implantable device. A shock therapy delay period is timed in response to the detection of the patient therapy request. Atrial shock therapy is provided to the patient after expiration of the shock therapy delay period (if the presence of an ongoing atrial arrhythmia is detected). The patient therapy request may be provided by a patient activator including a magnet for operating a reed switch in the implanted device to provide the request. A patient activator including an input and receiver/transmitter circuitry may be employed to request the immediate providing of atrial shock therapy, and/or to set the duration of the shock therapy delay period. By allowing specific delays to therapy after a therapy request, a patient can prepare for the requested therapy and thereby mitigate therapy discomfort.
    Type: Grant
    Filed: April 20, 2001
    Date of Patent: September 9, 2003
    Assignee: Cardiac Pacemakers, Inc.
    Inventors: Victor T. Chen, Gary T. Seim, Carlos Ricci, Michael L. Favet, Hal Propp
  • Publication number: 20020156504
    Abstract: An implanted cardiac device detects an atrial arrhythmia and provides periodically updated atrial arrhythmia status as long as the arrhythmia is ongoing. A patient may request an indication of ongoing atrial arrhythmia status from external to the patient using a patient activator. The patient activator may include a magnet for closing a reed switch in the implanted device to provide the request or may provide the request over a telemetry link to the implanted device. The implanted device may provide the requested atrial arrhythmia status and other information in the form of an audible tone produced by the implanted device or as a message telemetered from the implanted device to the patient activator. The patient activator may include a tone detector and display for providing a visual indication of the atrial arrhythmia status indication. The magnet activator may also be employed to request or withhold atrial shock therapy.
    Type: Application
    Filed: April 20, 2001
    Publication date: October 24, 2002
    Inventors: Victor T. Chen, Gary T. Seim, Hal Propp, LeAnne Eberle, Lynn TeWinkel
  • Publication number: 20020156505
    Abstract: An implantable cardiac device detects a patient therapy request originating from external to the implantable device. A shock therapy delay period is timed in response to the detection of the patient therapy request. Atrial shock therapy is provided to the patient after expiration of the shock therapy delay period (if the presence of an ongoing atrial arrhythmia is detected). The patient therapy request may be provided by a patient activator including a magnet for operating a reed switch in the implanted device to provide the request. A patient activator including an input and receiver/transmitter circuitry may be employed to request the immediate providing of atrial shock therapy, and/or to set the duration of the shock therapy delay period. By allowing specific delays to therapy after a therapy request, a patient can prepare for the requested therapy and thereby mitigate therapy discomfort.
    Type: Application
    Filed: April 20, 2001
    Publication date: October 24, 2002
    Inventors: Victor T. Chen, Gary T. Seim, Carlos Ricci, Michael L. Favet, Hal Propp
  • Patent number: 6470210
    Abstract: Systems and methods are provided for analyzing occurrences of atrial arrhythmias. Occurrences of each of a number of classified atrial arrhythmia rhythms are detected. The classified atrial arrhythmias may, for example, include at least atrial fibrillation and atrial flutter. A duration of time associated with each of the detected atrial arrhythmia rhythms is measured. Trend data is produced with respect to a predetermined period of time using all or selected ones of the measured time durations. The detecting, measuring, and producing processes may also be performed for one or more unclassified atrial arrhythmias.
    Type: Grant
    Filed: April 6, 2001
    Date of Patent: October 22, 2002
    Assignee: Cardiac Pacemakers, Inc.
    Inventors: Victor Chen, Gary Seim, Carlos Ricci, LeAnne Eberle, Hal Propp, Clayton Foster
  • Publication number: 20020147408
    Abstract: Systems and methods are provided for analyzing occurrences of atrial arrhythmias. Occurrences of each of a number of classified atrial arrhythmia rhythms are detected. The classified atrial arrhythmias may, for example, include at least atrial fibrillation and atrial flutter. A duration of time associated with each of the detected atrial arrhythmia rhythms is measured. Trend data is produced with respect to a predetermined period of time using all or selected ones of the measured time durations. The detecting, measuring, and producing processes may also be performed for one or more unclassified atrial arrhythmias.
    Type: Application
    Filed: April 6, 2001
    Publication date: October 10, 2002
    Inventors: Victor Chen, Gary Seim, Carlos Ricci, LeAnne Eberle, Hal Propp, Clayton Foster